AI Summary
Thinking
Thinking
We reviewed 3 live results for biospecimens and narrowed them down to the 3 options that look most worth comparing first.
The options are Access Rare Disease Samples from Patients Worldwide, Peripheral Blood Mononuclear Cells (PBMCs) and Biospecimen Samples & Sample Services.
Source: Labtoo
Description
Labtoo provides a customized procurement service sourcing rare disease biological samples from patients worldwide for clinical and translational research. Sourcing covers diverse specimens including fresh, frozen, and FFPE tissues, whole blood, PBMC, plasma, serum, CSF, urine, and saliva from individuals with genetic and orphan conditions. Operating through retrospective biobank searches or tailored prospective clinical collections across Europe, North America, and international sites, Labtoo manages feasibility studies, ethical approvals, regulatory compliance, contracting, and material transfer.
Best for
Biotechnology Companies, Pharmaceutical Companies and Procuring rare and orphan disease biospecimens for drug discovery and biomarker research
Rate this product
Source: Discovery Life Sciences
Description
Discovery Life Sciences provides healthy and diseased Peripheral Blood Mononuclear Cells (PBMCs) isolated from over 1,100 patients for immunology, oncology, and advanced cell therapy research. Available from an extensive inventory or prospective collections, these viable cell biospecimens include longitudinal and matched sets with BMMCs, DTCs, FFPE, or tumoroids. Products are immunophenotyped by flow cytometry, characterized for cell count and viability via AO/PI staining, and cryopreserved in 1.0 mL aliquots containing approximately 5 million cells.
Best for
Immunology researchers, Oncology researchers, Immunology research and Oncology research
Rate this product
Source: RayBiotech
Description
RayBiotech provides biospecimen samples and sample services supporting drug discovery, biomarker discovery, target validation, lead optimization, translational research, and clinical development. Offerings include retrospective banked human specimens and prospective customized studies across diverse biospecimens, focusing on biofluids such as whole blood, dried blood, blood cells, PBMCs, plasma, serum, urine, saliva, and DNA. Specimens feature clinical and demographic data, matched sets, healthy controls, or specific medical conditions, managed under IRB-approved protocols complying with 21 CFR part 11, HIPAA, and GLP standards.
Best for
Researchers, Drug discovery scientists, Biomarker discovery and Target validation
Rate this product
| Compare | #1Access Rare Disease Samples from Patients Worldwide | #2Peripheral Blood Mononuclear Cells (PBMCs) | #3Biospecimen Samples & Sample Services |
|---|---|---|---|
| Source | Labtoo | Discovery Life Sciences | RayBiotech |
| Description | Labtoo provides a customized procurement service sourcing rare disease biological samples from patients worldwide for clinical and translational research. Sourcing covers diverse specimens including fresh, frozen, and FFPE tissues, whole blood, PBMC, plasma, serum, CSF, urine, and saliva from individuals with genetic and orphan conditions. Operating through retrospective biobank searches or tailored prospective clinical collections across Europe, North America, and international sites, Labtoo manages feasibility studies, ethical approvals, regulatory compliance, contracting, and material transfer. | Discovery Life Sciences provides healthy and diseased Peripheral Blood Mononuclear Cells (PBMCs) isolated from over 1,100 patients for immunology, oncology, and advanced cell therapy research. Available from an extensive inventory or prospective collections, these viable cell biospecimens include longitudinal and matched sets with BMMCs, DTCs, FFPE, or tumoroids. Products are immunophenotyped by flow cytometry, characterized for cell count and viability via AO/PI staining, and cryopreserved in 1.0 mL aliquots containing approximately 5 million cells. | RayBiotech provides biospecimen samples and sample services supporting drug discovery, biomarker discovery, target validation, lead optimization, translational research, and clinical development. Offerings include retrospective banked human specimens and prospective customized studies across diverse biospecimens, focusing on biofluids such as whole blood, dried blood, blood cells, PBMCs, plasma, serum, urine, saliva, and DNA. Specimens feature clinical and demographic data, matched sets, healthy controls, or specific medical conditions, managed under IRB-approved protocols complying with 21 CFR part 11, HIPAA, and GLP standards. |
| Best for | Biotechnology Companies, Pharmaceutical Companies and Procuring rare and orphan disease biospecimens for drug discovery and biomarker research | Immunology researchers, Oncology researchers, Immunology research and Oncology research | Researchers, Drug discovery scientists, Biomarker discovery and Target validation |
| Action | Labtoo | Discovery Life Sciences | RayBiotech |
| Rate this product |
"Access Rare Disease Samples from Patients Worldwide from Labtoo."
Note: TopFind AI compiles product and service information for general comparison purposes only.